Abstract
Machine learning has become a powerful tool in forecasting, offering greater accuracy than traditional human predictions in today’s data-driven world. The capability of machine learning to predict future trends has significant implications for key sectors such as finance, healthcare, and supply chain management. In this study, ARIMA/SARIMA (AutoRegressive Integrated Moving Average/Seasonal AutoRegressive Integrated Moving Average), alongside Prophet, a scalable forecasting tool developed by Facebook based on a generalized additive model, are considered. These models are applied to predict the demand for antidiabetic drugs. The records were collected by the Australian Health Insurance Commission. This dataset was sourced from Medicare Australia. The study evaluates the performance of these models based on their Mean Absolute Error (MAE), a key metric for assessing forecast accuracy. Root Mean Squared Error (RMSE) and Mean Absolute Percentage Error (MAPE) are also considered. The outcome of the comparative analysis shows that the Prophet model outperformed both ARIMA and SARIMA models, achieving an MAE of 0.74, which is significantly lower than the MAE values of 2.18 and 3.02 obtained by SARIMA and ARIMA, respectively. Prophet's superior performance shows its effectiveness in handling complex, non-linear trends and seasonal patterns often observed in real-world time series data. This research contributes to the growing knowledge of machine learning-based forecasting and shows the importance of advanced models like Prophet in optimizing business operations and driving innovation. The findings from this research offer valuable guidance for data experts, analysts, and researchers in selecting the best forecasting methods for reliable predictions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.